Prescription medicines transparency measures: Implementation of generic medicines early notification to innovators of an application and publication of innovator application
The submission to the Therapeutic Goods Administration was prepared by the Intellectual Property Committee of the Business Law Section.
The Committee makes the following comments in relation to the consultation regarding ‘Prescription medicines transparency measures: Implementation of generic medicines early notification to innovators of an application and publication of innovator application’ (March 2020).
You can read the full submission below.
Share
Related Documents
Tags
Most recent items in Business Law Section
Business Law Section
Insolvency Reforms to Support Small Business
Business Law Section
Major reform of the Foreign Investment Review Framework - Tranche 2
Business Law Section
Extension to temporary insolvency emergency measures
Trending Items in Business Law Section
Business Law Section
Forsyth/Pose Scholarship
Business Law Section
Santow Scholarship
Business Law Section